Table 4 Secondary outcomes according to treatment and timing
From: STeroids Against Radiculopathy (STAR) trial: a statistical analysis plan
| Â | Intervention group 1, mean (SD) | Intervention group 2, mean (SD) | Control group, mean (SD) | Comparison 1, treatment effect, mean difference (95% CI) | Comparison 2, treatment effect, mean difference (95% CI) | Comparison 3, treatment effect, mean difference (95% CI) | |
|---|---|---|---|---|---|---|---|
Outcome | |||||||
 Health-related quality of life | Overall effect |  |  |  | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ |
Baseline | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
3 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
6 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
12 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
26 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
 Patient satisfaction | Overall effect |  |  |  | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ |
Baseline | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
3 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
6 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
12 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
26 weeks | X (XX) | X (XX) | X (XX) | X (XX–XX)_ | X (XX–XX)_ | X (XX–XX)_ | |
Total number of surgeries performed | 26 weeks | X | X | X | X | X | X |